Skip to main content

Pregabalin

NDC 68788-7520 · Preferred Pharmaceuticals, Inc.

Generic namePREGABALIN
Dosage formCAPSULE
RouteORAL
Active ingredient(s)PREGABALIN
Strength25 mg/1
DEA scheduleCV
Marketing categoryANDA

Packages

68788-7520-1 — 100 CAPSULE in 1 BOTTLE (68788-7520-1)

68788-7520-3 — 30 CAPSULE in 1 BOTTLE (68788-7520-3)

68788-7520-6 — 60 CAPSULE in 1 BOTTLE (68788-7520-6)

68788-7520-9 — 90 CAPSULE in 1 BOTTLE (68788-7520-9)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

67046-1680 — Pregabalin, 67877-457 — Pregabalin, 67877-462 — Pregabalin, 67877-463 — Pregabalin, 67877-464 — Pregabalin, 67877-465 — Pregabalin, 67877-466 — Pregabalin, 67877-467 — Pregabalin, 67877-468 — Pregabalin, 67877-469 — Pregabalin, 68788-7521 — PREGABALIN, 68788-7522 — PREGABALIN, 68788-7523 — PREGABALIN, 68788-7524 — PREGABALIN, 68788-7527 — PREGABALIN, 68788-7656 — PREGABALIN, 68788-8360 — Pregabalin, 68788-8391 — Pregabalin, 68788-8472 — Pregabalin, 68788-8667 — Pregabalin, +519 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels